France to boost coronavirus vaccine for all adults… Reinforcement of masks and health certificates


In response to the spread of COVID-19, France has decided to implement booster shot vaccinations for all adults and strengthen regulations on masks and health certificates.

French Health Minister Olivier Verand announced at a press conference that starting this weekend, all adults over the age of 18 will be able to use the booster shot.

The period from the second inoculation to the booster shot is shortened from 6 months to 5 months.

Currently, the French booster shot is only available to people over 65 years of age, but the Higher Health Administration (HAS) recently recommended that the target be expanded to those over 40.

Minister Verand said France currently has 25 million doses of the vaccine.

He said he would ask the Health Department and the Medical Ethics Committee to review vaccinations for children aged 5-11.

The European Medicines Agency (EMA) has recommended the approval of the Pfizer vaccine for children aged 5 to 11 years.

Minister Verang also said that a health certificate is issued only after the booster shot is completed.

In France, when entering restaurants, cafes and theaters, you need a health certificate with information such as vaccination completion or negative results.

He also said that in order to increase the burden on unvaccinated people, the validity period of a health certificate’s genetic amplification (PCR) test results will be shortened from 72 hours to one day.

From the 26th, wearing a mask will become mandatory again in all indoor spaces.

The number of new confirmed cases in France on the previous day was 32,591, the highest in seven months.

It is the first time since the end of April that it recorded more than 30,000 for two days in a row.

France, however, said it does not need a full-scale lockdown like Austria did.

The intensive care unit is still at an acceptable level.

“Vaccines, health certificates, and social distancing are weapons we already have,” said Minister Verand, explaining that from early December, Merck’s oral treatment for COVID-19, Molnupiravir, will be the first to be added in Europe.

(Photo = Getty Images Korea)

Leave a Reply

Your email address will not be published. Required fields are marked *